Exploratory Analysis Results from Post-marketing Surveillance Study of Radium-223 in Japanese Patients with Castration-resistant Prostate Cancer and Bone Metastases: Subgroup Analysis by Age

Exploratory Analysis Results from Post-marketing Surveillance Study of Radium-223 in Japanese Patients with Castration-resistant Prostate Cancer and Bone Metastases: Subgroup Analysis by Age

Objective: To perform an exploratory analysis on the safety and effectiveness of radium-223 (Ra-223) by patient baseline age, using the results of a post-marketing surveillance study of Ra-223 in castration-resistant prostate cancer patients with bone metastasis in Japan. Method: The safety analysis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:KAKUIGAKU 2021, Vol.58(1), pp.91-101
Hauptverfasser: HOSONO, Makoto, UEMURA, Hirotsugu, KAKEHI, Yoshiyuki, MASUMORI, Naoya, TAKAHASHI, Shunji, OKAYAMA, Yutaka, SUNAYA, Toshiyuki, HORIO, Tomoyo, KINUYA, Seigo
Format: Artikel
Sprache:jpn
Schlagworte:
Aged
bone metastases
Bone Neoplasms - radiotherapy
castration-resistant prostate cancer
Humans
Japan
Japanese patients
Laboratories, Clinical
Male
post-marketing surveillance study
Product Surveillance, Postmarketing
Prostatic Neoplasms, Castration-Resistant
Radioisotopes
Radium - adverse effects
radium-223
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To perform an exploratory analysis on the safety and effectiveness of radium-223 (Ra-223) by patient baseline age, using the results of a post-marketing surveillance study of Ra-223 in castration-resistant prostate cancer patients with bone metastasis in Japan. Method: The safety analysis population of 296 patients was stratified into two groups based on age (
ISSN:2189-9932
DOI:10.18893/kakuigaku.oa.2105